Mitoquinone
Showing 1 - 17 of 17
SARS-CoV Infection, COVID-19 Trial (Mitoquinone/mitoquinol mesylate, Placebo)
Not yet recruiting
- SARS-CoV Infection
- COVID-19
- Mitoquinone/mitoquinol mesylate
- Placebo
- (no location specified)
Jun 1, 2023
Respiratory Viral Infection, Antiviral Treatment, COVID-19 Trial in Los Angeles (Mitoquinone/mitoquinol mesylate)
Recruiting
- Respiratory Viral Infection
- +2 more
- Mitoquinone/mitoquinol mesylate
-
Los Angeles, CaliforniaUniversity of California Los Angeles
Aug 3, 2022
Aging, Endothelial Dysfunction, Cardiovascular Function Trial in Muncie (Placebo, Mitoquinone Mesylate)
Completed
- Aging
- +3 more
- Placebo
- Mitoquinone Mesylate
-
Muncie, IndianaBall State University
May 22, 2023
Frailty, Mild Cognitive Impairment, Aging Trial in Farmington (Mitoquinone Mesylate, Placebo capsule)
Not yet recruiting
- Frailty
- +2 more
- Mitoquinone Mesylate
- Placebo capsule
-
Farmington, ConnecticutUConn Health
Sep 7, 2023
Long-COVID Trial in Salt Lake City (Mitoquinone, Placebo)
Recruiting
- Long-COVID
- Mitoquinone
- Placebo
-
Salt Lake City, UtahVA Salt Lake City Health Care System, Salt Lake City, UT
Nov 23, 2022
Insulin Resistance Trial in Copenhagen (Intralipid, 20% Intravenous Emulsion, MitoQ, Salbutamol)
Completed
- Insulin Resistance
- Intralipid, 20% Intravenous Emulsion
- +2 more
-
Copenhagen, DenmarkAugust Krogh Building
Dec 1, 2021
Breast Tumors Trial (Mitoquinone, Placebo)
Not yet recruiting
- Breast Neoplasms
- Mitoquinone
- Placebo
- (no location specified)
Mar 31, 2022
Multiple Sclerosis, Fatigue Trial in Portland (Mitoquinone)
Completed
- Multiple Sclerosis
- Fatigue
- Mitoquinone
-
Portland, OregonOregon Health & Science University
Apr 9, 2020
Diastolic Dysfunction Trial in Aurora (MITOQUINOL MESYLATE then , Placebo, then MITOQUINOL MESYLATE)
Recruiting
- Diastolic Dysfunction
- MITOQUINOL MESYLATE then placebo
- Placebo, then MITOQUINOL MESYLATE
-
Aurora, ColoradoUniversity of Colorado
Aug 22, 2022
Healthy Trial in Copenhagen (MitoQ)
Unknown status
- Healthy
- MitoQ
-
Copenhagen, DenmarkAugust Krogh Building
Sep 20, 2019
Aging, Oxidative Stress, Vascular Endothelium Trial in Salt Lake City (MITO-AO, PB-125, Placebo)
Recruiting
- Aging
- +4 more
- MITO-AO
- +6 more
-
Salt Lake City, UtahVA Medical Center
Apr 14, 2022
Racial Disparities, Blood Pressure, Cardiovascular Risk Factor Trial in Auburn (MitoQ)
Recruiting
- Racial Disparities
- +3 more
- MitoQ
-
Auburn, AlabamaKinesiology Building
Aug 31, 2022
Cardiovascular Diseases, Hypertension, Racism Trial in Auburn (MitoQ)
Recruiting
- Cardiovascular Diseases
- +3 more
- MitoQ
-
Auburn, AlabamaAuburn University
Jan 31, 2023
Non-alcoholic Fatty Liver Disease Trial in Newcastle-upon-Tyne (Mitoquinone mesylate, Placebo)
Terminated
- Non-alcoholic Fatty Liver Disease
- Mitoquinone mesylate
- Placebo
-
Newcastle-upon-Tyne, United KingdomFreeman Hospital
May 28, 2011
Chronic Hepatitis C Trial in Auckland, Hamilton (Mitoquinone mesylate (MitoQ))
Completed
- Chronic Hepatitis C
- Mitoquinone mesylate (MitoQ)
-
Auckland, New Zealand
- +1 more
Aug 12, 2008